Vaping
71
15
19
38
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
18 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
2.8%
2 terminated out of 71 trials
95.0%
+8.5% vs benchmark
6%
4 trials in Phase 3/4
47%
18 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (71)
TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths
Cessation of Smoking Trial in the Emergency Department
Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues
Social Media Support Groups for Adolescent Vaping Cessation
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
The Canadian Lung Outcomes in Users of Vaping Devices Study
To Vape or Not to Vape
The Use of tDCS for Vaping Reduction
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
Social Media Vaping Cessation Pilot With Peer Mentors
Influencer Marketing and Adolescent E-cigarette Use
Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping
A Virtual Reality Game to Prevent E-cigarette and Cannabis Vaping
Persistence of Oral DNA Adducts in Smokers and Vapers
Vape Use Among Younger & Older Smokers
Adolescent Inpatient Tobacco and ENDS Intervention
Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
A Virtual Reality Vaping Prevention Intervention for Adolescents